Clinicopathological characteristics of cutaneous lupus erythematosus patients in Bangladesh

被引:3
作者
Plachouri, Kerasia-Maria [1 ,4 ]
Mulita, Francesk [2 ]
Oikonomou, Chrysa [1 ]
Papadopoulou, Margarita [3 ]
Akrida, Ioanna [2 ]
Vryzaki, Eleftheria [1 ]
Verras, Georgios-Ioannis [2 ]
Georgiou, Sophia [1 ]
机构
[1] Univ Gen Hosp Patras, Dept Dermatol, Patras, Greece
[2] Univ Gen Hosp Patras, Dept Surg, Patras, Greece
[3] PA Kyriakou Childrens Hosp, Dept Ophthalmol, Athens, Greece
[4] Univ Gen Hosp Patras, Dept Dermatol, Rion 26504, Greece
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2022年 / 39卷 / 04期
关键词
cutaneous lupus erythematosus; Chittagong; Bangladesh; URTICARIA-LIKE LESIONS; RISK-FACTORS; MANIFESTATIONS; DISEASE; CLASSIFICATION; EPIDEMIOLOGY;
D O I
10.5114/ada.2021.110254
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Nearly all epidemiologic studies have involved patients with systemic lupus erythematosus (SLE). Few authors have investigated the characteristics of patients with cutaneous lupus erythematosus (CLE). Aim: To describe the clinical and pathologic characteristics of a series of patients diagnosed with CLE. Material and methods: This is a descriptive retrospective cross-sectional study carried out using the consecutive registered records of 218 patients attending the 'Lupus Clinic' in Chittagong Medical College Hospital during the period between 2010 and 2020. The activity and damage of CLE were assessed according to the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI). Results: There were 187 (85.8%) females and 31(14.2%) males, with the female:male ratio being 6 : 1. The mean age was 30.0 +/- 11.7 years. The chronic cutaneous lupus erythematosus (CCLE) patients numbered 154 (70.6%), followed by acute cutaneous lupus erythematosus (ACLE) n = 46 (21.1%), and subacute cutaneous lupus erythematosus (SCLE) n = 18 (8.3%). In LE-specific skin lesions, the most common manifestation was photosensitivity, 198 (90.8%), followed by discoid rash, 155 (71.1%) and maculo-papular lupus rash, 55 (25.2%). Among LE-nonspecific skin lesions, the most common manifestation was non-scarring alopecia, 123 (56.4%), followed by livedo reticularis, 18 (8.3%), Raynaud's phenomenon, 17 (7.8%), vasculitis, 15 (6.9%), periungual telangiectasia, 7 (3.2%), erythema multiforme, 6 (2.7%) and leg ulcers, 5 (2.3%). Antinuclear antibodies (ANA) were the most common type of autoantibody (n = 132, 60.5%) followed by anti-ds DNA (n = 91, 41.7%) and anti-phospholipid antibodies (n = 9, 4.1%). Conclusions: CCLE was the most common subtypes of CLE. Photosensitivity was the most common clinical manifestation, whereas ANA were the most frequent autoantibodies of the LE patients of this region. Patients with different subtypes of CLE have distinct clinical and pathological characteristics.
引用
收藏
页码:782 / 787
页数:6
相关论文
共 28 条
  • [1] The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus
    Albrecht, J
    Taylor, L
    Berlin, JA
    Dulay, S
    Ang, G
    Fakharzadeh, S
    Kantor, J
    Kim, E
    Militello, G
    McGinnis, K
    Richardson, S
    Treat, J
    Vittorio, C
    Van Voorhees, A
    Werth, VP
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (05) : 889 - 894
  • [2] Clinical and immunological manifestations in 151 SLE patients living in Dubai
    AlSaleh, J.
    Jassim, V.
    ElSayed, M.
    Saleh, N.
    Harb, D.
    [J]. LUPUS, 2008, 17 (01) : 62 - 66
  • [3] Binoy JP., 2003, J Indian Rheumatol Assoc, V11, P94
  • [4] The spectrum of cutaneous manifestations in lupus erythematosus - the Italian experience
    Cardinali, C
    Caproni, M
    Bernacchi, E
    Amato, L
    Fabbri, P
    [J]. LUPUS, 2000, 9 (06) : 417 - 423
  • [5] SYSTEMIC LUPUS-ERYTHEMATOSUS - CLINICAL AND IMMUNOLOGICAL PATTERNS OF DISEASE EXPRESSION IN A COHORT OF 1,000 PATIENTS
    CERVERA, R
    KHAMASHTA, MA
    FONT, J
    SEBASTIANI, GD
    GIL, A
    LAVILLA, P
    DOMENECH, I
    AYDINTUG, AO
    JEDRYKAGORAL, A
    DERAMON, E
    GALEAZZI, M
    HAGA, HJ
    MATHIEU, A
    HOUSSIAU, F
    INGELMO, M
    HUGHES, GRV
    CERVERA, R
    SEBASTIANI, GD
    FONT, J
    KHAMASHTA, MA
    HUGHES, GRV
    FONT, J
    CERVERA, R
    LOPEZSOTO, A
    VIVANCOS, J
    INGELMO, M
    URBANOMARQUEZ, A
    KHAMASHTA, MA
    VIANNA, J
    HUGHES, GRV
    GIL, A
    LAVILLA, P
    PINTADO, V
    LOPEZDUPLA, M
    VAZQUEZ, JJ
    SEBASTIANI, GD
    DERAMON, E
    CAMPS, M
    FRUTOS, MA
    PERELLO, I
    SANTOS, PG
    ABARCA, M
    NEBRO, AF
    DOMENECH, I
    TOKGOZ, G
    AYDINTUG, AO
    JEDRYKAGORAL, A
    MALDYKOWA, H
    CHWALINSKASADOWSKA, H
    GALEAZZI, M
    [J]. MEDICINE, 1993, 72 (02) : 113 - 124
  • [6] Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus
    Chong, B. F.
    Song, J.
    Olsen, N. J.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (01) : 29 - 35
  • [7] Contin-Bordes C, 2009, REV MED INTERNE, V30, P9
  • [8] Cooper GS, 1998, ARTHRITIS RHEUM, V41, P1714, DOI 10.1002/1529-0131(199810)41:10<1714::AID-ART3>3.3.CO
  • [9] 2-L
  • [10] A MULTI-CENTER STUDY OF OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS .1. ENTRY VARIABLES AS PREDICTORS OF PROGNOSIS
    GINZLER, EM
    DIAMOND, HS
    WEINER, M
    SCHLESINGER, M
    FRIES, JF
    WASNER, C
    MEDSGER, TA
    ZIEGLER, G
    KLIPPEL, JH
    HADLER, NM
    ALBERT, DA
    HESS, EV
    SPENCERGREEN, G
    GRAYZEL, A
    WORTH, D
    HAHN, BH
    BARNETT, EV
    [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (06): : 601 - 611